How Will Checkpoint Inhibitors Be Incorporated Into Unresectable HCC Treatment

Ghassan Abou-Alfa, MD, MBA of Memorial Sloan Kettering gives his view on checkpoint inhibitors and their incorporation into treatment for unresectable HCC at the 2017 Gastrointestinal Cancers Symposiu... Author: obr Added: 01/24/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts